Start reading ,This title and over 12000 thousand more,available with Avenue Library, T&C*
Europe Drug Coated Endotracheal Tube Market by Type (Oral or Nasal Tube, Cuffed or Uncuffed Tube, Preformed Tube, Reinforced Tube, and Double-Lumen Endobronchial Tube), Coating Type (Antithrombotic Drug Coated, and Antiproliferative Drug Coated), Application (Benign Prostatic Hyperplasia (BPH), Ureteral Stenosis, Prostatic Cancer, Esophageal Stricture, Sinus Stenosis, and Biliary Stricture), and End User (Hospital, and Medical Center) - Opportunity Analysis and Industry Forecast, 2021-2028
| A03285 | Pages: NA | Aug 2021 | 3590 Views | | |
| Author(s) : NA | Tables: NA | Charts: NA | Formats*: | |
COVID-19
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Europe Drug Coated Endotracheal Tube Market
Request Now !Endotracheal tube is a catheter introduced in the trachea to confirm the adequate exchange of oxygen and carbon dioxide and maintains the patients airway. Drug coated endotracheal tube is a specific tube coated with drug such as polyvinyl chloride and is nearly always inserted through the mouth or nose.
The major factor that contributes to the growth of the European drug coated endotracheal tube market includes rise in number of chronic respiratory diseases such as cardiovascular diseases, respiratory diseases, diabetes, cancer, and other lung injuries. Moreover, increase in geriatric population, who are more prone to chronic diseases, and development in R&D activities also boost the market growth. However, stringent approval process hamper the market growth. The development of novel products by key vendors, mainly to avoid ventilator-associated pneumonia (VAP) condition by preventing bacterial colonization and biofilm formation on tube surface, further provide lucrative growth opportunities for the market.
European drug coated endotracheal tube market is segmented on the basis of type, coating type, application, end user, and country. Based on type, it is divided into oral or nasal tube, cuffed or uncuffed tube, preformed tube, reinforced tube, and double-lumen endobronchial tube. Based on coating type, it is segmented into antithrombotic drug coated, and antiproliferative drug coated. On the basis of application, the market is categorized into benign prostatic hyperplasia (BPH), ureteral stenosis, prostatic cancer, esophageal stricture, sinus stenosis, and biliary stricture. On the basis of end user, the market is classified into hospital, medical center, and others (clinics and ambulatory surgical centers). By country, the market is analyzed across Germany, France, UK, Italy, Spain, and rest of Europe.
The key players operating in the market include Teleflex Corporation, C. R. Bard, Inc., AirWay Technologies, Inc., Allvivo Vascular, Inc., BRIO DEVICE LLC, Medtronic, Smiths Group plc, Becton, Dickinson and Company, Enox Biopharma, Inc, and Merit Medical Systems, Inc.
Key Benefits
- The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
- The report provides information about the current and upcoming trends in the market from 2016 to 2023, which helps determine the prevailing opportunities.
- Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
- Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence the market are provided.
- Key market players are profiled and their strategies are analyzed thoroughly, which help understand the competitive outlook of the market.
Europe Drug Coated Endotracheal Tube Market Key Segments:
By Type
- Oral or Nasal Tube
- Cuffed or Uncuffed Tube
- Preformed Tube
- Reinforced Tube
- Double-Lumen Endobronchial Tube
By Coating Type
- Antithrombotic Drug Coated
- Antiproliferative Drug Coated
By Application
- Benign Prostatic Hyperplasia (BPH)
- Ureteral Stenosis
- Prostatic Cancer
- Esophageal Stricture
- Sinus Stenosis
- Biliary Stricture
By End User
- Hospitals
- Medical Centers
- Others (Clinics and Ambulatory Surgical Centers)
By Country
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTERS FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
CHAPTER 4 EUROPE DRUG COATED ENDOTRACHEAL TUBE MARKET, BY TYPE
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. ORAL OR NASAL TUBE
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. CUFFED OR UNCUFFED TUBE
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.4. PREFORMED TUBE
4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
4.5. REINFORCED TUBE
4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast
4.6. DOUBLE-LUMEN ENDOBRONCHIAL TUBE
4.6.1. Key market trends
4.6.2. Growth factors and opportunities
4.6.3. Market size and forecast
CHAPTER 5 EUROPE DRUG COATED ENDOTRACHEAL TUBE MARKET, BY COATING TYPE
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. ANTITHROMBOTIC DRUG COATED
5.2.1. Market size and forecast
5.3. ANTIPROLIFERATIVE DRUG COATED
5.3.1. Market size and forecast
CHAPTER 6 EUROPE DRUG COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. BENIGN PROSTATIC HYPERPLASIA (BPH)
6.2.1. Market size and forecast
6.3. URETERAL STENOSIS
6.3.1. Market size and forecast
6.4. PROSTATIC CANCER
6.4.1. Market size and forecast
6.5. ESOPHAGEAL STRICTURE
6.5.1. Market size and forecast
6.6. SINUS STENOSIS
6.6.1. Market size and forecast
6.7. BILIARY STRICTURE
6.7.1. Market size and forecast
CHAPTER 7 EUROPE DRUG COATED ENDOTRACHEAL TUBE MARKET, BY END USER
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. HOSPITALS
7.2.1. Market size and forecast
7.3. MEDICAL CENTERS
7.3.1. Market size and forecast
7.4. OTHERS
7.4.1. Market size and forecast
CHAPTER 8 EUROPE DRUG COATED ENDOTRACHEAL TUBE MARKET, BY COUNTRY
8.1. OVERVIEW
8.2. KEY MARKET TRENDS
8.3. KEY GROWTH FACTORS AND OPPORTUNITIES
8.4. MARKET SIZE AND FORECAST
8.4.1. Germany market size and forecast
8.4.2. France market size and forecast
8.4.3. UK market size and forecast
8.4.4. Italy market size and forecast
8.4.5. Spain market size and forecast
8.4.6. Rest of Europe market size and forecast
CHAPTER 9 COMPANY PROFILES
9.1. TELEFLEX CORPORATION
9.1.1. Operating business segments
9.1.2. Business performance
9.1.3. Key strategic moves and developments
9.2. C. R. BARD, INC.
9.2.1. Operating business segments
9.2.2. Business performance
9.2.3. Key strategic moves and developments
9.3. AIRWAY TECHNOLOGIES, INC.
9.3.1. Operating business segments
9.3.2. Business performance
9.3.3. Key strategic moves and developments
9.4. ALLVIVO VASCULAR, INC.
9.4.1. Operating business segments
9.4.2. Business performance
9.4.3. Key strategic moves and developments
9.5. BRIO DEVICE LLC
9.5.1. Operating business segments
9.5.2. Business performance
9.5.3. Key strategic moves and developments
9.6. MEDTRONIC PLC.
9.6.1. Operating business segments
9.6.2. Business performance
9.6.3. Key strategic moves and developments
9.7. SMITHS GROUP PLC.
9.7.1. Operating business segments
9.7.2. Business performance
9.7.3. Key strategic moves and developments
9.8. BECTON, DICKINSON AND COMPANY
9.8.1. Operating business segments
9.8.2. Business performance
9.8.3. Key strategic moves and developments
9.9. ENOX BIOPHARMA, INC.
9.9.1. Operating business segments
9.9.2. Business performance
9.9.3. Key strategic moves and developments
9.10. MERIT MEDICAL SYSTEMS, INC.
9.10.1. Operating business segments
9.10.2. Business performance
9.10.3. Key strategic moves and developments
We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:
- Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
- Technologically sophisticated and reliable insights through well audited and veracious research methodology
- Sovereign research proceeds that present a tangible depiction of marketplace
With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.
Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, web-casts and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast
Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develops analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth and forecasts
Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:
- Chief executives and VPs of leading corporations specific to industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)
Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
Access from any device, anywhere
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
REQUEST TOC/SAMPLE
Purchase Full Report of
Europe Drug Coated Endotracheal Tube Market- Opportunity Analysis and Industry Forecast, 2021-2028
- Online Only
-
$3,456$3,110 - Online cloud access only
- Restricted print, copy, paste & download
- Read only
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
10%
Discount
- Data Pack
-
$3,840$3,456 - Restricted to one authorized user
- One print only
- Available in
Excel - Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
10%
Discount
- Single User
-
$5,769$5,192 - Restricted to one authorized user
- One print only
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
10%
Discount
- Five Users
-
$6,450$5,805 - Limited to five authorized users
- Print upto five copies
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
10%
Discount
-
Enterprise
License/PDF -
$8,995$8,096 - Unlimited
within
company/enterprise - Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
10%
Discount
- Library Membership
- $ 699/mo
- Published Content
E-access - Company Profiles
E-access - Newly Added Content Access
- 10 PDF
Downloads - 5 Excel Data
Pack Downloads - 250 Company Profiles PDF Downloads
-
Start reading.
Buy Now
This title and over 12,000+ are available on the Avenue Library. T&C*.
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
Why Allied Market Research?
Infallible Methodology
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
Analyst Support
For complete satisfaction
Customization
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET VIEW
Targeted market view to provide pertinent information and save time of readers
Get fresh content delivered
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Why Allied Market Research?
Infallible Methodology
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
Analyst Support
For complete satisfaction
Customization
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET VIEW
Targeted market view to provide pertinent information and save time of readers